 |  |
VIA EDGAR | September 10, 2019 |
| Re: | Acceleration Request for 10x Genomics, Inc. |
Registration Statement on Form S-1 (File No. 333-233361) |
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Russell Mancuso
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, we attach the requests of our client, 10x Genomics, Inc., and of the underwriters that effectiveness of the above-referenced Registration Statement be accelerated to 4:00 p.m., Eastern Time, on September 11, 2019, or as soon as practicable thereafter. We ask, however, that the Securities and Exchange Commission staff not accelerate such effectiveness until we speak with you on that date.
Call me at (650) 251-5130 with any questions.
Very truly yours,
/s/ Kevin P. Kennedy
Kevin P. Kennedy
September 10, 2019
VIA EDGAR
| Re: | 10x Genomics, Inc. |
Registration Statement on Form S-1 |
File No. 333-233361 |
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E. Washington, D.C. 20549
Attention: Russell Mancuso
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, 10x Genomics, Inc. (the “Company”) hereby requests that the effective date of the above-referenced Registration Statement be accelerated so that it may become effective at 4:00 p.m., Eastern Time, on September 11, 2019, or as soon as possible thereafter. In this regard, the Company is aware of its obligations under the Securities Act.
If you require any additional information with respect to this letter, please contact Kevin Kennedy (650-251-5130) of Simpson Thacher & Bartlett LLP.
[Signature Page Follows]
Very truly yours, | ||||
| 10X GENOMICS, INC. | ||||
| By: | /s/ Eric S. Whitaker | |||
| Name: | Eric S. Whitaker | |||
| Title: | General Counsel | |||
[Signature Page to Company Acceleration Request Letter]
September 10, 2019
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attention: Russell Mancuso
Thomas Jones
Gary Newberry
Lynn Dicker
| Re: | 10x Genomics, Inc. |
Registration Statement on Form S-1 (File No. 333-233361) |
Ladies and Gentlemen:
Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that as of the date hereof, approximately 2,900 copies of the Preliminary Prospectus dated September 10, 2019 were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement.
We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on September 11, 2019 or as soon thereafter as practicable.
[Signature page follows]
Very truly yours,
J.P MORGAN SECURITIES LLC
GOLDMAN SACHS & CO. LLC
BOFA SECURITIES, INC.
As representatives of the Underwriters
By: | J.P. Morgan Securities LLC | |
By: | /s/ Ben Burdett | |
| Name: Ben Burdett | ||
| Title: Managing Director | ||
By: | Goldman Sachs & Co. LLC | |
By: | /s/ Elizabeth Wood | |
| Name: Elizabeth Wood | ||
| Title: Managing Director | ||
By: | BofA Securities, Inc. | |
By: | /s/ Adam Chazan | |
| Name: Adam Chazan | ||
| Title: Managing Director | ||
[Signature Page to Underwriters Acceleration Letter]